Middle East & Africa ECMO Market

The Middle East & Africa ECMO Market is expected to grow from US$ 29.74 million in 2022 to US$ 33.54 million by 2028. It is estimated to record a CAGR of 2.0% from 2022 to 2028.

Growing Adoption of ECMO in Lung Transplantation Procedures Drives

Lung transplantation is a life-saving treatment option for patients suffering from end-stage lung diseases, such as COPD, Idiopathic pulmonary fibrosis (IPF), and cystic fibrosis, to improve the quality of life. ECMO is a versatile tool used in all lung transplantation phases, such as preoperative, intraoperative, and postoperative periods. It acts as a bridge for a patient undergoing lung transplantation. Therefore, the adoption of ECMO during lung transplantation is growing rapidly to manage patients with life-threatening lung diseases. Primary graft dysfunction (PGD) is the leading cause of death after a lung transplant. ECMO is used penultimately in treating PGD post lung transplantation. Thus, the demand for ECMO equipment is growing for treating patients suffering from PGD.

Middle East & Africa  ECMO Market Overview

 

The Middle East & Africa  is segmented into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. South Africa holds the largest market share in the Middle East & Africa  during forecast period. South Africa faces a burden of chronic cardiovascular diseases, including high hypertension and cardiac arrest. The country is experiencing an increasing burden of cardiovascular diseases, including coronary heart disease (CHD) and stroke. According to WHO, it is estimated that the rate of premature death due to CVD amongst South African adults is projected to increase by 41% between 2000 and 2030. Moreover, in South Africa, stroke is a leading cause of death and disability. The burden of stroke is expected to increase in the coming years as the population is experiencing a rapid epidemiological transition with increased exposure to and development of stroke risk factors, together with the aging of the population. Healthcare facilities in South Africa are developing and adopting the latest technologies to offer better treatments and diagnoses. Although the region remains highly exposed to political uncertainty, medical device exports will gain from accelerated economic growth in Sub-Saharan Africa, which will be aided by increased commodity prices and improved investor enthusiasm. In Sub-Saharan Africa, South Africa is the key business center for the medical device industry. A large percentage of medical device and lab equipment exports go to other African countries, with 12 African countries among the top 20 export destinations. Thus, owing to the above-mentioned factors, the country is expected to provide an opportunistic scenario for the ECMO market growth in South Africa during the forecast period.

Middle East & Africa

 ECMO Market Revenue and Forecast to 2028 (US$ Million)

 

Middle East & Africa ECMO Strategic Insights

Strategic insights for the Middle East & Africa ECMO provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Middle East & Africa ECMO Report Scope

Middle East & Africa ECMO Regional Insights

The geographic scope of the Middle East & Africa ECMO refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

Middle East & Africa ECMO Market Segmentation

 

The Middle East & Africa ECMO market is segmented based on modality, application, age group, and country.    

Based on modality, the Middle East & Africa ECMO market is segmented into venoarterial ECMO, venovenous ECMO, and arteriovenous ECMO. The venoarterial ECMO segment held the largest market share in 2022.

Based on application, the Middle East & Africa ECMO market is bifurcated into respiratory and cardiology. The respiratory segment held a larger market share in 2022.

Based on age group, the Middle East & Africa ECMO market is segmented into adults, pediatrics, and neonates. The adults segment held the largest market share in 2022.

Based on country, the Middle East & Africa ECMO market has been categorized into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. Our regional analysis states that South Africa dominated the market in 2022.

ABIOMED Inc, Braile Biomedica, Fresenius Medical Care AG & Co KGaA, Getinge AB, LivaNova Plc, Medtronic Plc, MicroPort Scientific Corporation, Nipro Medical Corporation, and Terumo Group are the leading companies operating in the MEA ECMO market.